Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-19-033740
Filing Date
2019-11-26
Accepted
2019-11-26 14:14:25
Documents
1
Period of Report
2019-11-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6975
  Complete submission text file 0001127602-19-033740.txt   8290
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 333 LAKESIDE DRIVE FOSTER CITY X1 94404
Business Address
Pletcher Brett A (Reporting) CIK: 0001739307 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19731 | Film No.: 191249679